Cancer cells and pluripotent stem cells frequently exhibit gains or losses of entire chromosomes and chromosome segments, and the typical terminal analyses of genomes suggest this aneuploidy is ongoing and particularly variable in solid tumors. Here, we quantify aneuploidy-inducing perturbations by live cell fluorescence monitoring for changes in chromosome-5 in a lung cancer line and in normal diploid iPS cells. Inhibition of the spindle assembly checkpoint (SAC) and knockdown of DNA repair factors cause chromosome mis-segregation to increase several-fold above a low baseline level, and both perturbations also generate several-fold more rare fluorescent-null cells. Loss of chromosome-5 is confirmed by single cell karyotyping, SNP arrays on stable isolated clones, and downregulated expression of genes on chromosome-5 in single cell transcriptomics. The iPS cells also show loss of fluorescence in infrequent cells after SAC inhibition and upon growth as teratomas in mice. Viability, selection, and altered expression can thus be tracked to reveal molecular mechanisms in aneuploidy. (156 words)
Introduction
Copy number changes are a major form of genomic variation in cancer (Hastings et al., 2009; Zhang et al., 2009 ) and are often more common than somatic mutations. A recent study of medulloblastoma, for example, shows the most frequently detected mutation (in MYC) occurs in only 17% of patients whereas every one of more than a dozen copy number changes occur in more than 30% of patients (Northcott et al., 2017) . In clinical trials by Yamanaka and colleagues on two aged patients (>65 yrs), induced pluripotent stem (iPS) cells generated from one of the patients exhibited copy number variations that prevented their use for fear of causing cancer (Mandai et al., 2017) . Mechanisms for copy number variation remain unclear, and reported changes are likely to reflect selection and affect gene expression (i.e. gene dosage).
Current methods to assess copy number variations require DNA extractions for sequencing and arrays or else viable mitotic cells for metaphase spreads, but such methods are terminal experiments for cells. Rare changes (~1% of cells) are also difficult to be confident in, and whether a given change yields a viable cell can at best be inferred.
A live cell reporter for copy number changes in rare cells might address such issues and be useful to decipher mechanisms. A recently reported live reporter in yeast has used changes in intensity of a chromosome-integrated, GFP-tagged gene to hint at copy number changes, but validations and imaging were limited (Lauer et al., 2018) . In various human cancers, many chromosomes are lost or gained, and loss of Chr-5 is commonly seen in gastric, esophageal, lung, ovarian and breast cancer (Johannsdottir et al., 2006; Mendes-da-Silva et al., 2000; Michelassi et al., 1989; Ogasawara et al., 1996; Tavassoli et al., 1996) . Here, we describe a chromosome-5 (chr-5) reporter in live human-derived cells with detailed copy number characterizations and perturbations, followed by corresponding gene expression assessments and sample studies both in vitro and in vivo.
Results

Loss of chromosome 5 reporter in live cells
We hypothesized that fusing a GFP variant protein to a housekeeping gene in one allele of Chr-5 will allow us to look for loss of the fluorescent signal and relate to loss of all or part of Chr-5 ( Fig. 1A) . The lung cancer line (A549) is hypotriploid, and one of the three copies of chr-5 is gene-edited with RFP fused to the N-terminus of a housekeeping protein while protein from the other two chr-5s is unaltered ( Fig. S1A) . Modified cells all express RFP signal after cell sorting. After weeks in standard culture, however, some RFP-neg cells were evident as viable colonies with no obvious growth defects ( Fig. 1B) . RFP-neg cells were clonally expanded for genomic characterization in order to test our hypothesis.
Karyotyping of ten metaphase spreads showed 90% of RFP-neg cells with only two copies of chr-5 whereas RFP-positive cells always showed three copies (Fig. 1C) .
Karyotype variation in the bulk population of RFP-pos otherwise reflects the genomic instability of these cancer cells (Fig. 1C ), and even in clonal RFP-neg cells, the one month of culture needed for clonal expansion reveals a loss of chr-12 in cell #1 and a revertant gain of chr-5 in cell #10 (Fig. 1C ). To confirm the loss of RFP, PCR used one primer in the RFP region and a second primer in the native fused gene: no band is detected in RFPneg cells compared to RFP-pos, and the sensitivity is ~1:1000 or better ( Fig. S1B) . again reveal chr-5 loss in RFP-neg clones (Fig. 1D) . A few differences between karyotyping and SNP arrays include only one chr-6 in metaphase spreads of RFP-neg cells (Fig. 1C,D) , but detailed analyses indicate a translocation of chr-6 to chr-1.
SNP (Single Nucleotide Polymorphism) array analysis for copy number changes
Unidentified chromosomes in karyotyping will also be detected in SNP arrays such as the gain of chromosome segments on chr-3 ( Fig. S1C) . Regardless, after correction and subtraction of RFP-pos from RFP-neg, the two methods agree with each other (Fig. S1Cbottom ) and consistently show loss of RFP signal in cells correlates with a loss of chr-5 ( Fig. 1C , D, S1C-bottom).
Reversine & DNA repair factor knockdown increase RFP-neg cell numbers
In normal cells, mis-segregation of chromosomes is prevented by the spindle assembly checkpoint (SAC), which inhibits mitotic exit until all chromosomes have achieved bipolar attachment to spindle microtubules (Barbosa et al., 2011; Lara-Gonzalez et al., 2012) .
Reversine perturbs SAC and drives appearance of RFP-neg cells in a dose-dependent manner easily quantified by flow cytometry (Fig. 1E) , which suggests a loss of chr-5.
Depletion of DNA repair factors upon nuclear envelope rupture causes excess DNA damage and might also produce copy number changes Xia et al., 2018) . Knockdown of multiple DNA repair factors (i.e. KU80, BRCA1, and BRCA2) indeed drives increased genomic heterogeneity in the samples ( Fig. S2 ) and ~3-fold more cells become RFP-neg ( Fig. 1F) . Combination of this knockdown with reversine suggests an additive effect ( Fig. 1F ), consistent with orthogonal functions of SAC and DNA repair in genomic stability.
Dividing cancer cells exhibit ~10% abnormalities in a standard assay for lagging chromosomes (Fig. 1G) , which may explain the appearance of ~0.5% RFP-neg cells in long-term cultures of pure RFP-pos cells (Fig. 1E,F) . However, such aneuploidy increases to nearly ~40% (~3 fold) after reversine treatment or knockdown of DNA repair factors (Fig.   1G ). The fold increase in mitotic errors is consistent with the fold-increase in RFP-neg cells under the same perturbation ( Fig. 1F ).
Gene expression correlates with chromosome numbers
Cell-to-cell variations in epigenetic states generally add complexity to gene expression profiles, but copy number variation seem detectable in transcript profiles per a 'gene dosage' effect (Raznahan et al., 2018; Gao et al., 2016) . To minimize complexities of cellto-cell variation, single cell RNA-seq was applied to four RFP-neg clones and four RFPpos clones as two mixtures. Chromosome copy numbers of eight clones were also assessed by SNP array and again show loss of one copy of three chr-5's in RFP-neg cells ( Fig. S3) . Single cell RNA-seq showed 7385 genes account for >95% of total reads, which were normalized by Transcripts Per Kilobase Million (TPM) (Hwang et al., 2018; Vallejos et al., 2017) . Comparing RFP-neg and RFP-pos cells reveals a Chr-5 specific, chromosome-wide decrease in gene expression (by ~1/3 rd ) at both single cell and bulk levels ( Fig. 2A) .
Single cell RNA-seq has been applied to distinguish different cell types in tissues as these cells typically have distinct gene expression profiles, and the results can be validated by means such as marker-specific immunostaining (Przepiorski et al., 2018) .
RFP is the principal marker here, but heterogeneity due to the mixture of four RFP-neg clones can also be identified using t-SNE and k-means analysis ( Fig. 2B) (Grün et al., 2015) . A large intermingled population in t-SNE and k-mean plots is likely due to two RFPneg clones having an identical genome ( Fig. 2B -ii&C-i). However, loss of chr-17 in a separate population and loss of chr-8, 15 and 19 in the another population correlate well with each genotype as well ( Fig. 2Ci -ii). The "chr-5 reporter system" thus suggests that single cell RNA-seq can clarify gene dosage and separate cancer cell sub-populations with minor difference in genotypes.
Phenotypic differences can also associate with genotypic differences
Although the four RFP-pos clones exhibit similar genotypes, clone-1 uniquely gains a chromosome 7 q-arm (Fig. 3A) . The copy number changes in chromosome 7 have been seen in many diseases such as 7q11.23 duplication syndrome and Williams-Beuren syndrome, which causes delayed cell growth and neurological problems (Berg et al., 2007; Sanders et al., 2011) . Cells in clone-1 exhibit slightly delayed proliferation and less spindle-polraized morphology ( Fig. 3B,C) . As cell migration requires polarization (Ridley et al., 2003) , live imaging was done on sparse culture. Clone-1 proves to be less migratory than any other clone, with no directional bias obvious in any clone ( Fig. 3D) . Although further bioinformatic analysis is required to resolve mechanism(s) linking genotype and phenotype, we had shown in a similar study that an extra copy of Chr-8 increases GATA4, which promotes microtubule assembly, spindle shapes, and faster migration in 3D .
Normal diploid iPS cells may lose chromosomes in vitro and in vivo
Cancer cells typically possess intrinsic genomic instability and tend to gain or lose chromosomes (Negrini et al., 2010 )such as chr-5 in culture ( Fig. 1A,B ). In comparison, iPS cells derived from a young adult human with similar gene editing of chr-5 are stable, showing 100% GFP-pos after weeks of culture. SNP array analysis of bulk cultures also show no copy number variation. Synchronizing cell cycle of iPS cells by nocodazole causes severe cell death and the remaining survivors do not divide even after release.
However, iPS cells survived reversine treatment for a few passages, and some GFP-pos iPS cells became GFP-neg based on both flow cytometry and imaging (Fig. 4A) .
Our GFP-pos iPS cells grow robustly in clusters and double every 12 hrs in standard culture, but GFP-neg iPS cells do not persist (Fig. 4A ). This is probably because 1) normal cells intrinsically lose survivability after chromosome loss (Teng and Hardwick, 2015) , and 2) a standard culture environment on Matrigel-coated plastic is not suitable to support genomically-aberrant cells. In particular, aged mouse-iPS cells with genomic instability can be diverted into apoptosis by improving the DNA damage response with 'simple' addition of a cell-permeable antioxidant during reprogramming (Skamagki et al., 2017) . This exciting, recent finding did not address, however, whether abnormal genomes in the source cells (eg. fibroblasts) are the origins of the genomic changes in the iPS cells as often proposed.
Teratomas in an NSG mouse were made by subcutaneous flank injections of the iPS cells following other studies (Gutierrez-Aranda et al., 2010; Nelakanti et al., 2015) .
After 4 wks, cells dissociated from teratoma and other tissues such as brain were analyzed by flow cytometry or else cultured on Matrigel-coated plastic. Mouse and human cells can be clearly distinguished by anti-human antibody based on control studies with mouse melanoma-derived B16F10 cells ( Fig. S4A ). Using the same staining and flow cytometry settings, GFP-neg iPS cells were detected by both flow cytometry and imaging ( Fig. 4B,C) .
Cells seem to have differentiated already as abundant lamin-A is seen and they no longer grow in clusters ( Fig. S4B) . All isolated GFP-neg cells from the teratoma again died by 2 wks in culture, even though most of the isolated GFP-pos iPS cells remain viable in culture.
Nonetheless, the appearance of GFP-neg iPS cells at least suggest some stresses in vivo are sufficient to cause aneuploidy among normal iPS cellseven though loss of all of part of or the entire chr-5 must be assessed by methods above.
Conclusion
The chromosome reporter in live cells demonstrated here has the potential for the study of factors that cause copy number changes in both cancer cells and normal cells. Although we only show chr-5 loss in our characterization, chr-5 gain is also detectable in theory.
Ultimately, if one can label all chromosomes with different colors, then all chromosomes can be monitored simultaneously. Although there is a correlation between copy number changes and gene expression, the change is usually ~30-50% when a gain or loss of the chromosome is seen. Many cancers cells indeed express markers that are many times more than that in normal cells, which may not be a simple effect caused by chromosome changes, but more complicated secondary responses may be involved to cause the issues and could be illuminated by the approaches here.
Material and Methods
Cell culture
A549 cells were cultured in F12 media (A549), supplemented with 10% FBS and 1% penicillin/streptomycin under 37 o C and 5% CO2 as recommended by ATCC. When drug treatment is required, 1.5µM reversine was used for 24 hrs, followed by releasing for 48 hrs. If imaging on mitotic cells is needed, after DMSO or reversine treatment, the media was replaced with 1.5µg /ml Nocodazole for 18 hrs and released in pure media for 1 hr.
All iPS cells were cultured in mTeSR1 medium, supplemented with 5X growth factors, incubated at 37°C and 5% CO2. Plastic well plates were coated with Matrigel in DMEM media for 1 hr before cells were plated.
Immunostaining
Cells were fixed in 4% formaldehyde (Sigma) for 15 minutes, followed by permeabilization by 0.5% Triton-X (Sigma) for 15 minutes, and blocked with 5% BSA (Sigma) for 30 minutes and overnight incubation in primary antibodies (anti-human). The cells were then incubated in secondary antibodies (1:500 ThermoFisher) for 1.5 hours, and their nuclei were stained with 8μM Hoechst 33342 (ThermoFisher) for 15 minutes. When mounting is involved, Prolong Gold antifade reagent was used (Invitrogen, Life Technologies).
Imaging
Epifluorescence imaging was performed using an Olympus IX71 with a digital camera (Photometrics) and a 40X/0.6 NA objective. Confocal imaging was performed on a Leica TCS SP8 system with a 63X/1.4 NA oil-immersion. Live imaging was performed on an EVOS FL Auto Imaging System with 10× or 20× object in normal culture conditions (37°C and 5% CO2; complete culture medium as specified above).
Transfection/Knockdown
All siRNAs used in this study were purchased from Dharmacon (ON-TARGETplus SMARTpool siBRCA1, L-003461-00; siBRCA2, L-003462-00; siKu80, L-010491-00).
A549 cells were passaged 24 hours prior to transfection. A complex of siRNA pool (25 nM each) and 1 µg/mL Lipofectamine 2000 was prepared according to the manufacturer's instructions and incubated for 3 days (for siRNAs) in corresponding media with 10% FBS.
Knockdown efficiency was determined by Immunoblot following standard methods .
Flow cytometry / Sorting
For flow cytometry, A549 cells were dissociated using 0.05% trypsin for 5 min, washed in PBS, and re-suspended in 5% FBS in PBS. Samples were run on a BD LSRII Flow Cytometer.
For sorting, cells were prepared in the same way as flow cytometry, except that cells were kept sterile. FACS Aria (BD Biosciences) was used to sort. Sorted cells were collected in 15ml centrifuge tubes, with 10% FBS and 1% P/S in corresponding media (complete media as described in cell culture section). Sorted cells were then centrifuged with 3000 rpm for 5 min and cultured back in T25 or T75 flasks.
If immunostaining is need for flow cytometry, cells were washed with PBS after trypsinization, resuspended in 5% BSA in PBS and put onto a rotator for 15min. Cells were then centrifuged, supernatant discarded; the same process was applied with 1:500 FC receptor in 5% BSA. Next, cells were resuspended in 1:500 primary antibody (anti-human), left on rotator for 20 min, centrifuged, supernatant discarded, and washed once with 1%FBS in PBS. The same process was repeated for secondary antibody, also at 1:500 dilution. Finally, cells were resuspended in 5% FBS with PBS, and run on flow cytometer as described before.
Karyotyping
Cells used for karyotyping were plated in T25 flasks, cultured for 2-3 days to reach half confluency. The media was then discarded and replaced with new media to fill the entire flask with a closed lid, wrapped with parafilm. The samples were then sent to a company to conduct karyotyping. 
Genome (SNP array) analysis
Teratoma in vivo
For each injection, iPS cells were suspended in 300 μL ice-cold PBS and 30% Matrigel (BD) and injected subcutaneously into the flank of non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice with null expression of interleukin-2 receptor gamma chain (NSG mice) . Mice were obtained from the University of Pennsylvania Stem Cell and Xenograft Core. All animal experiments were planned and performed according to IACUC protocols. The teratoma were grown for 4 weeks and cells from teratoma and other tissues were then isolated for culture and flow cytometry.
Statistics
All statistical analyses were performed using Excel (2013; Microsoft) or MATLAB. Unless otherwise noted, statistical comparisons were made by unpaired two-tailed Student's t tests and were considered significant if p < 0.05. Unless mentioned, all plots show mean ± SEM. n indicates the number of samples, cells, or wells quantified in each experiment. 
Figure legends
